Nan Fung Group Holdings Ltd
Q4 2025 13F Holdings
- Locationkai tak, K3
- Num holdings
27
- Value ($000)
$111,726
- Date Filed02/13/2026
- Form type13F-HR
- CIK0001782539
- All SEC filings
- NoteHoldings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q4 2025 toSelect Quarter
Issuer Name | Class | CUSIP | VALUE | % | Shares | Principal | Option Type |
|---|---|---|---|---|---|---|---|
EVOMMUNE INC | COM SHS | 30054Y107 | $24.67M | 22 % | 1,441,032 | ||
MAPLIGHT THERAPEUTICS INC | COM | 56565P103 | $17.06M | 15 % | 971,253 | ||
OCULIS HOLDING AG | ORDINARY SHARES | H5870P102 | $10.28M | 9 % | 514,702 | ||
MADRIGAL PHARMACEUTICALS INC | COM | 558868105 | $6.91M | 6 % | 11,872 | ||
LB PHARMACEUTICALS INC | COM SHS | 50180M108 | $6.68M | 6 % | 300,000 | ||
INCYTE CORP | COM | 45337C102 | $5.83M | 5 % | 59,022 | ||
RHYTHM PHARMACEUTICALS INC | COM | 76243J105 | $5.26M | 5 % | 49,120 | ||
BEONE MEDICINES LTD | SPONSORED ADS | 07725L102 | $4.78M | 4 % | 15,722 | ||
PROCORE TECHNOLOGIES INC | COM | 74275K108 | $3.88M | 4 % | 53,299 | ||
CYBIN INC | COM NEW | 23256X407 | $3.76M | 3 % | 460,000 |
Rows Per Page
10
- 5
- 10
- 20
- 30
- 50
- 100